TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation

被引:4
|
作者
Zhou, Shouzhi [1 ]
Yang, Zhao [2 ]
Liu, Jiaxin [2 ]
Ran, Maojuan [2 ]
机构
[1] Chongqing Med Univ, Yongchuan Hosp, Dept Proctol, Chongqing 402160, Peoples R China
[2] Chongqing Med Univ, Yongchuan Hosp, Dept Geriatr, Chongqing 402160, Peoples R China
关键词
TIPE-2; Inflammatory bowel disease; STAT3; NF-kB; NEGATIVE REGULATOR; GUT MICROBIOTA; IMMUNITY; EXPRESSION; RESPONSES; TNFAIP8; INNATE;
D O I
10.1016/j.imlet.2023.02.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TIPE-2 has been identified as a negative regulator of both innate and adaptive immunity and is involved in several inflammatory diseases. However, the immune inhibition mechanism of TIPE-2 involved in inflammatory bowel disease has not been well studied. Therefore, the aim of this study was to investigate whether TIPE-2 improved experimental colitis by reducing high levels of inflammation in the intestine. Lentivirus encoding TIPE-2 was administered to mice by intrarectal injection after colitis induction. Histological analysis was used to analyze sections of the intestine. Protein expression induced by STAT3 and NF-kappa B signaling was analyzed by western blot. We found that TIPE-2 reduced the colitis activity index score and the histological score of the intestine. TIPE-2 also decreased inflammatory cytokine levels in the intestine. Additionally, TIPE-2 inhibited STAT3 and NF-kB activation. These results suggested that TIPE-2 might attenuate inflammation of colitis via inhibiting of STAT3 and NF-kB activation.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [41] Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers
    Ji, Zhe
    He, Lizhi
    Regev, Aviv
    Struhl, Kevin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (19) : 9453 - 9462
  • [42] STAT3 and NF-kB Regulate S100A7 Expression in Human Bronchial Epithelial Cells
    Hulse, K. E.
    Singh, R.
    Chaung, K.
    Norton, J.
    Harris, K.
    Conley, D.
    Chandra, R.
    Kern, R.
    Peters, A.
    Grammer, L.
    Tan, B.
    Carter, R.
    Seshadri, S.
    Suh, L.
    Kato, A.
    Schleimer, R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB68 - AB68
  • [43] Transcriptional factors NF-kB and STAT3 are overexpressed in invasive ductal breast carcinomas and triple negative subgroup
    Meseure, D.
    Alsibai, K. Drak
    Trassard, M.
    Lerebours, F.
    Lidereau, R.
    Bieche, I.
    VIRCHOWS ARCHIV, 2011, 459 : S77 - S77
  • [44] Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice
    Jung, Hong Soo
    Joo, Jin-Deok
    Kim, Dae-Woo
    In, Jang Hyeok
    Roh, Misun
    Jeong, Jong-Tae
    Noh, Seung June
    Choi, Jin Woo
    KOREAN JOURNAL OF ANESTHESIOLOGY, 2014, 66 (02) : 136 - 142
  • [45] Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas Through NF-kB/STAT3 Signaling
    Schweiger, Markus W.
    Li, Mao
    Fleming, Renata
    Tabet, Elie
    Tannous, Bakhos
    MOLECULAR THERAPY, 2020, 28 (04) : 510 - 510
  • [46] STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility
    Cenit, M. C.
    Alcina, A.
    Marquez, A.
    Mendoza, J. L.
    Diaz-Rubio, M.
    de las Heras, V.
    Izquierdo, G.
    Arroyo, R.
    Fernandez, O.
    de la Concha, E. G.
    Matesanz, F.
    Urcelay, E.
    GENES AND IMMUNITY, 2010, 11 (03) : 264 - 268
  • [47] ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-KB signaling pathway
    Huang, Wei
    Tang, Hao
    Liu, Yang
    Li, WenWei
    Shimu, Ajmeri Sultana
    Li, BoFeng
    Zhu, Chen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [48] STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility
    M C Cénit
    A Alcina
    A Márquez
    J L Mendoza
    M Díaz-Rubio
    V de las Heras
    G Izquierdo
    R Arroyo
    O Fernández
    E G de la Concha
    F Matesanz
    E Urcelay
    Genes & Immunity, 2010, 11 : 264 - 268
  • [49] PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease
    Ibrahim, Sidikjan
    Zhu, Xu
    Luo, Xuelai
    Feng, Yongdong
    Wang, Jing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
  • [50] Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-KB and STAT3 inhibitors
    Zeng, Binglin
    Cheng, Yu
    Zheng, Kailu
    Liu, Shuoxiao
    Shen, Longying
    Hu, Jinping
    Li, Yan
    Pan, Xiandao
    BIOORGANIC CHEMISTRY, 2021, 111